A dose-escalating phase I study with valproic acid (VPA) in patients (pts) with advanced cancer

MLA

A. Atmaca, et al. “A Dose-Escalating Phase I Study with Valproic Acid (VPA) in Patients (Pts) with Advanced Cancer.” Journal of Clinical Oncology, vol. 22, July 2004, p. 3169. EBSCOhost, https://doi.org/10.1200/jco.2004.22.90140.3169.

APA

A. Atmaca, A. Maurer, T. Heinzel, M. Göttlicher, A. Neumann, S.-E. Al-Batran, E. Martin, I. Bartsch, A. Knuth, & E. Jaeger. (2004). A dose-escalating phase I study with valproic acid (VPA) in patients (pts) with advanced cancer. Journal of Clinical Oncology, 22, 3169. https://doi.org/10.1200/jco.2004.22.90140.3169

Chicago

A. Atmaca, A. Maurer, T. Heinzel, M. Göttlicher, A. Neumann, S.-E. Al-Batran, E. Martin, I. Bartsch, A. Knuth, and E. Jaeger. 2004. “A Dose-Escalating Phase I Study with Valproic Acid (VPA) in Patients (Pts) with Advanced Cancer.” Journal of Clinical Oncology 22 (July): 3169. doi:10.1200/jco.2004.22.90140.3169.